About this item:

61 Views | 30 Downloads

Author Notes:

Ahmed Elbanna, Email: elbanna2@illinois.edu

M.D.B., P.J.H., T.M.F., R.L.S., N.D.G., W.C.S., J.T.W., S.A.M., A.C.C., R.J.J., and T.L.K. conceived, designed, and guided the research, M.D.B., P.J.H., T.M.F., R.L.S., N.D.G., W.C.S.,A.El., and D.R.E.R. wrote the paper, M.D.B., P.J.H., T.M.F., N.D.G., R.L.S., W.C.S., A.El., J.T.W., C.B.B., A.V, S.A.M., A.C.C., R.J.J., T.L.K., K.C.W., K.W., R.S.W., E.V., S.V., E.A.T., M.A.T., R.T. M.S., C.Sm., T.H.S., C.Sk., J.M.S., A.S., M.E.S., L.N.R., E.R., M.L.R., J.R., J.Q., M.C.P., C.P., J.M.P., J.P., A.P., N.A.P., M.N., A.D.M., K.M., M.M., H.H.M., J.Mo., A.Mir., K.G.M., R.M., J.Ma., Y.C.M., R.L.L., L.M.K., T.K., A.K., P.K., I.J., N.I., A.A.H., A.H., R.M.H., A.G., B.G., D.G., S.A.G., N.Gas., N.Gal., B.W.F., D.F., J.F., T.E., A.Ed., J.E., M.Cu., M.Co., A.C., J.Bu., J.Bl., I.B., J.D.B., K.M.B., M.B., R.L.B., M.J.L., J.E.N., N.J.C., D.L.Y., M.H.L., G.S., J.C.C., M.G., J.S.M., R.B., J.A.V., J.L., W.E.W., D.B.Y., D.S.S., S.P.B., L.M., P.K.A., E.A.V., M.J., J.L.S., A.C.V., C.H., R.N.K., J.A.P., C.Si., J.Br., D.M.K., N.W., G.D., C.B.-P., B.R.B., L.W-B., M.DL., K.D., M.R.F.J., J.D.S., C.B., E.S., R.C.P.J., P.M.H., M.P.S., T.J.N., J.G., A.Mil., I.J.G., S.P.S. J.G.G., N.P.V., J.M.P., S.J.P., A.I., Z.L., H.Z., A.V.T., Z.J.W., S.M., J.U., G.N.W., T.W., R.L.F., L.W., K.J.G., F.G.A., R.L.H., and D.R.E.R. performed the research.

We gratefully acknowledge University of Illinois at Urbana-Champaign for funding. UIUC has also received support from CIMIT through the POCTRN program. CIMIT and POCTRN are supported by the RADx Tech program and have been funded in part with federal funds from the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Department of Health and Human Services, under Grant No. U54EB015408 awarded to R.L.S. With this work we would like to remember our colleague and co-author Joseph Gregory Gulick who passed away during the late stage of this project. He made critical contributions to the success of the SHIELD program. We would also like to acknowledge Michael Vincent and Diana Yates (Public Affairs, College of Media, University of Illinois at Urbana-Champaign) for editorial support.

University of Illinois at Urbana-Champaign has filed two pending patent applications related to the saliva-based assay described herein (US Nonprovisional Application No. 17/350,670, filed June 17, 2021; US National Phase Application No. 17/636,469, filed on February 18, 2022), and D.R.E.R., R.L.H., F.G.A., K.J.G., L.W., C.R.B., M.D.B., T.M.F., and P.J.H. are co-inventors. S.J.P., J.M.P., W.C.S., R.J.J., and A.C.C. are associated with Rokwire, which created the Safer Illinois App. G.D. and N.W. are associated with TekMill which created some of the automation used in the VDL COVID-19 Testing Lab at UIUC. P.J.H., A.C.C., S.A.M. and J.T.W. are Members of the Board of Managers for the University Related Organization SHIELD T3, LLC, which has obtained a non-exclusive license to this technology. The remaining authors declare no competing interests.

Subjects:

Research Funding:

This work was supported by the University of Illinois System Office, the Office of the Vice-Chancellor for Research and Innovation, the Grainger College of Engineering, and the Department of Physics at the University of Illinois at Urbana-Champaign.

Z.J.W. is supported in part by the United States Department of Energy Computational Science Graduate Fellowship, provided under Grant No. DE-FG02-97ER25308.

A.El. acknowledges partial support by NSF CAREER Award No. 1753249. This work made use of the Illinois Campus Cluster, a computing resource that is operated by the Illinois Campus Cluster Program (ICCP) in conjunction with the National Center for Supercomputing Applications (NCSA) and which is supported by funds from the University of Illinois at Urbana-Champaign.

This research was partially done at, and used resources of the Center for Functional Nanomaterials, which is a U.S. DOE Office of Science Facility, at Brookhaven National Laboratory under Contract No.~DE-SC0012704. This study was also partially funded by the National Institute for Biomedical Imaging and Bioengineering grant number U54EB027690, part of the National Institutes of Health.

Keywords:

  • Science & Technology
  • Multidisciplinary Sciences
  • Science & Technology - Other Topics
  • INFECTION
  • COVID-19

Mitigation of SARS-CoV-2 transmission at a large public university

Show all authors Show less authors

Tools:

Journal Title:

NATURE COMMUNICATIONS

Volume:

Volume 13, Number 1

Publisher:

, Pages 3207-3207

Type of Work:

Article | Final Publisher PDF

Abstract:

In Fall 2020, universities saw extensive transmission of SARS-CoV-2 among their populations, threatening health of the university and surrounding communities, and viability of in-person instruction. Here we report a case study at the University of Illinois at Urbana-Champaign, where a multimodal “SHIELD: Target, Test, and Tell” program, with other non-pharmaceutical interventions, was employed to keep classrooms and laboratories open. The program included epidemiological modeling and surveillance, fast/frequent testing using a novel low-cost and scalable saliva-based RT-qPCR assay for SARS-CoV-2 that bypasses RNA extraction, called covidSHIELD, and digital tools for communication and compliance. In Fall 2020, we performed >1,000,000 covidSHIELD tests, positivity rates remained low, we had zero COVID-19-related hospitalizations or deaths amongst our university community, and mortality in the surrounding Champaign County was reduced more than 4-fold relative to expected. This case study shows that fast/frequent testing and other interventions mitigated transmission of SARS-CoV-2 at a large public university.

Copyright information:

© The Author(s) 2022

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/rdf).
Export to EndNote